Search

Your search keyword '"Elsa M. Arribas"' showing total 4 results
Start Over Author "Elsa M. Arribas"
4 results on '"Elsa M. Arribas"'

1. Clinical situations for which 3D Printing is considered an appropriate representation or extension of data contained in a medical imaging examination: vascular conditions

Author

Joonhyuk Lee, Seetharam C. Chadalavada, Anish Ghodadra, Arafat Ali, Elsa M. Arribas, Leonid Chepelev, Ciprian N. Ionita, Prashanth Ravi, Justin R. Ryan, Lumarie Santiago, Nicole Wake, Adnan M. Sheikh, Frank J. Rybicki, and David H. Ballard

Subjects
3D printing, Appropriateness, Quality, Radiology, Additive manufacturing, Rapid prototyping, Medical physics. Medical radiology. Nuclear medicine, R895-920
Abstract

Abstract Background Medical three-dimensional (3D) printing has demonstrated utility and value in anatomic models for vascular conditions. A writing group composed of the Radiological Society of North America (RSNA) Special Interest Group on 3D Printing (3DPSIG) provides appropriateness recommendations for vascular 3D printing indications. Methods A structured literature search was conducted to identify all relevant articles using 3D printing technology associated with vascular indications. Each study was vetted by the authors and strength of evidence was assessed according to published appropriateness ratings. Results Evidence-based recommendations for when 3D printing is appropriate are provided for the following areas: aneurysm, dissection, extremity vascular disease, other arterial diseases, acute venous thromboembolic disease, venous disorders, lymphedema, congenital vascular malformations, vascular trauma, vascular tumors, visceral vasculature for surgical planning, dialysis access, vascular research/development and modeling, and other vasculopathy. Recommendations are provided in accordance with strength of evidence of publications corresponding to each vascular condition combined with expert opinion from members of the 3DPSIG. Conclusion This consensus appropriateness ratings document, created by the members of the 3DPSIG, provides an updated reference for clinical standards of 3D printing for the care of patients with vascular conditions.

Published
2023
Full Text
View/download PDF

2. Radiological Society of North America (RSNA) 3D Printing Special Interest Group (SIG) clinical situations for which 3D printing is considered an appropriate representation or extension of data contained in a medical imaging examination: breast conditions

Author

Elsa M. Arribas, Tatiana Kelil, Lumarie Santiago, Arafat Ali, Seetharam C. Chadalavada, Leonid Chepelev, Anish Ghodadra, Ciprian N. Ionita, Joonhyuk Lee, Prashanth Ravi, Justin R. Ryan, Adnan M. Sheikh, Frank J. Rybicki, David H. Ballard, and RSNA Special Interest 3D Printing Breast Conditions Voting Group

Subjects
Medical physics. Medical radiology. Nuclear medicine, R895-920
Abstract

Abstract The use of medical 3D printing has expanded dramatically for breast diseases. A writing group composed of the Radiological Society of North America (RSNA) Special Interest Group on 3D Printing (SIG) provides updated appropriateness criteria for breast 3D printing in various clinical scenarios. Evidence-based appropriateness criteria are provided for the following clinical scenarios: benign breast lesions and high-risk breast lesions, breast cancer, breast reconstruction, and breast radiation (treatment planning and radiation delivery).

Published
2023
Full Text
View/download PDF

3. Mid-treatment Ultrasound Descriptors as Qualitative Imaging Biomarkers of Pathologic Complete Response in Patients with Triple-Negative Breast Cancer

Author

Rosalind P. Candelaria, Beatriz E. Adrada, Deanna L. Lane, Gaiane M. Rauch, Stacy L. Moulder, Alastair M. Thompson, Roland L. Bassett, Elsa M. Arribas, Huong T. Le-Petross, Jessica W.T. Leung, David A. Spak, Elizabeth E. Ravenberg, Jason B. White, Vicente Valero, and Wei T. Yang

Subjects
Acoustics and Ultrasonics, Radiological and Ultrasound Technology, Chemotherapy, Adjuvant, Antineoplastic Combined Chemotherapy Protocols, Biophysics, Humans, Female, Triple Negative Breast Neoplasms, Radiology, Nuclear Medicine and imaging, Biomarkers, Neoadjuvant Therapy, Article
Abstract

This study aimed to investigate mid-treatment breast tumor ultrasound characteristics that may predict eventual pathologic complete response (pCR) in triple-negative breast cancer; specifically, we examined associations between pCR and two parameters: tumor response pattern and tumor appearance. Ultrasound was performed at mid-treatment, defined as the completion of four cycles of anthracycline-based chemotherapy and before receiving taxane-based chemotherapy. Consensus imaging review was performed while blinded to pathology results (i.e., pCR/non-pCR) from surgery. Tumor response pattern was described as "complete," "concentric," "fragmented," "stable" or "progression." Tumor appearance was designated as "mass," "architectural distortion," "flat tumor bed" or "clip only." Univariate and multivariate regression analyses of 144 participants showed significant associations between mid-treatment response pattern and pCR (p = 0.0348 and p = 0.0173, respectively), with complete and concentric response patterns more likely to achieve pCR than other patterns. Univariate and multivariate regression analyses further showed significant associations between mid-treatment tumor appearance and pCR (p0.0001 for both), with persistent appearance of mass less likely than other appearances to achieve pCR. To conclude, our study demonstrated strong associations between pCR and both tumor response pattern and tumor appearance, thereby suggesting that these parameters have potential as qualitative imaging biomarkers of pCR in triple-negative breast cancer.

Published
2022

4. Radiological Society of North America (RSNA) 3D Printing Special Interest Group (SIG) clinical situations for which 3D printing is considered an appropriate representation or extension of data contained in a medical imaging examination: Breast Conditions

Author

Elsa M. Arribas, Tatiana Kelil, Lumarie Santiago, Arafat Ali, Seetharam C. Chadalavada, Leonid Chepelev, Anish Ghodadra, Ciprian N. Ionita, Joonhyuk Lee, Prashanth Ravi, Justin Ryan, Adnan M. Sheikh, Frank J. Rybicki, and David H. Ballard

Abstract

The use of medical 3D printing has expanded dramatically for breast diseases. A writing group composed of the Radiological Society of North America (RSNA) Special Interest Group on 3D Printing (SIG) provides updated appropriateness criteria for breast 3D printing in various clinical scenarios. Evidence-based appropriateness criteria are provided for the following clinical scenarios: benign breast lesions and high-risk breast lesions, breast cancer, breast reconstruction, and breast radiation (treatment planning and radiation delivery).

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results